mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |